Company SinoMab BioScience Limited

3681

HK0000544194

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

Sector Biopharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 04:08:20 2024-04-26 am EDT			5-day change	1st Jan Change
1.9 ^HKD	0.00%		0.00%	+13.10%

Mar. 25	SinoMab BioScience Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 07	SinoMab BioScience Limited Appoints Shanchun Wang as an Executive Director	CI

SinoMab BioScience Ltd is a Hong Kong-based biopharmaceutical company mainly dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases. The Company primarily develops mAb-based biologics and new chemical entities (NCE). The Companyâs product SM03 is a mAb for the treatment of rheumatoid arthritis (RA). The Company is developing drugs for the treatment of RA, systemic lupus erythematosus (SLE), asthma, pemphigus, sjogrenâs syndrome (SS) and other immunological diseases.

Managers	Title	Age	Since
Shui On Leung CEO	Chief Executive Officer	64	01-04-26
Jian Ping Hua DFI	Director of Finance/CFO	42	18-12-31
Li Xin Zhang CTO	Chief Tech/Sci/R&D Officer	60	21-07-31
Shan Chun Wang BRD	Director/Board Member	56	21-12-31
Ka Wa Benny Cheung PRN	Corporate Officer/Principal	44	09-12-31
Kwan Yin Siu PRN	Corporate Officer/Principal	45	-
Ming Hon Yau PRN	Corporate Officer/Principal	45	11-12-31
Yuk Yin Chow SEC	Corporate Secretary	53	23-03-30

Members of the board	Title	Age	Since
Dylan Tinker BRD	Director/Board Member	55	19-10-30
Ping Cho Hon BRD	Director/Board Member	64	19-10-30
Hai Gang Chen BRD	Director/Board Member	41	17-07-31
Chi Ming Lee BRD	Director/Board Member	70	21-06-14
Wenyi Liu BRD	Director/Board Member	37	17-07-31
Shui On Leung CEO	Chief Executive Officer	64	01-04-26
George William Hunter Cautherley BRD	Director/Board Member	81	19-12-22
Xun Dong BRD	Director/Board Member	50	19-12-22
Lei Shi BRD	Director/Board Member	38	21-12-16
Jian Min Zhang BRD	Director/Board Member	47	23-09-05

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,091,755,119	412,298,663 ( 37.76 %)	0	37.76 %

Name	Equities	%	Valuation
Shanghai Xingze Investment Management Co. Ltd. 16.55 %	180,665,600	16.55 %	36 M $
CHINA CITIC BANK CORPORATION LIMITED 14.55 %	158,882,115	14.55 %	32 M $
Shui On Leung 11.88 %	129,729,200	11.88 %	26 M $
Si Jia Xu 8.225 %	89,802,105	8.225 %	18 M $
Jing Qiang 6.670 %	72,823,636	6.670 %	15 M $
YUNNAN BAIYAO GROUP CO.,LTD 4.613 %	50,357,700	4.613 %	10 M $
Shan Chun Wang 3.248 %	35,464,800	3.248 %	7 M $
Wenyi Liu 1.825 %	19,923,000	1.825 %	4 M $

Sinomab Bioscience Ltd.

Hong Kong Science Park, Pak Shek Kok No.15 Science Park West Avenue

, Hong Kong

http://www.sinomab.com

address SinoMab BioScience Limited(3681)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Biopharmaceuticals

	1st Jan change	Capi.
SINOMAB BIOSCIENCE LIMITED	+13.10%	265M
CSL LIMITED	-4.66%	87.53B
SAMSUNG BIOLOGICS CO.,LTD.	+1.32%	40.42B
BIOGEN INC.	-19.70%	29.48B
UCB	+57.86%	25.43B
INCYTE CORPORATION	-17.66%	11.49B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-44.02%	11.3B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9.14%	11.1B
SWEDISH ORPHAN BIOVITRUM AB	+5.24%	8.75B
INNOVENT BIOLOGICS, INC.	-8.42%	7.99B

Biopharmaceuticals